Detalles de la búsqueda
1.
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.
Contemp Clin Trials
; 104: 106335, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657443
Resultados
1 -
1
de 1
1
Próxima >
>>